NASDAQ:XENT
Delisted
Intersect ENT Stock News
$28.24
+0 (+0%)
At Close: Aug 17, 2022
Intersect ENT, Inc. (XENT) CEO Tom West on Q4 2020 Results - Earnings Call Transcript
03:06pm, Tuesday, 09'th Mar 2021
Intersect ENT, Inc. (XENT) CEO Tom West on Q4 2020 Results - Earnings Call Transcript
Intersect ENT Reports Fourth Quarter and Full Year 2020 Financial Results
07:00am, Tuesday, 09'th Mar 2021
MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT Reports Fourth Quarter 2020 Financial Results
A Preview Of Intersect ENT's Earnings
10:09am, Monday, 08'th Mar 2021
Intersect ENT (NASDAQ:XENT) releases its next round of earnings this Tuesday, March 09. Get the latest predictions in Benzinga's essential guide to the company's Q4 earnings report.
Why Earnings Season Could Be Great for Intersect ENT (XENT)
10:40am, Friday, 05'th Mar 2021
Intersect ENT (XENT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Intersect ENT to Report Fourth Quarter and Full Year 2020 Financial Results
04:05pm, Tuesday, 23'rd Feb 2021
MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT to Report Fourth Quarter and Full Year 2020 Financial Results
Intersect ENT Announces Launch of the New Straight Delivery System Packaged with the PROPEL® Mini Sinus Implant
07:00am, Thursday, 11'th Feb 2021
MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced t
Intersect ENT's (XENT) Q4 Preliminary Revenues Disappointing
10:32am, Monday, 18'th Jan 2021
Per the preliminary announcement, Intersect ENT (XENT) projects Q4 revenues to decline from the year-ago quarter's reported figure.
Intersect ENT (XENT) Banks on SINUVA Sales Amid COVID-19 Woes
11:18am, Thursday, 24'th Dec 2020
Intersect ENT's (XENT) potential in chronic sinusitis market and progress in SINUVA and PROPEL product lines are encouraging.
Intersect ENT to Present at the 39th Annual J.P. Morgan Healthcare Conference
04:05pm, Thursday, 17'th Dec 2020
MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT to Present at the 39th Annual J.P. Morgan Healthcare Conference
Intersect ENT Announces New Appointments to Executive Leadership Team
04:45pm, Tuesday, 17'th Nov 2020
MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT Announces New Appointments to Executive Leadership Team
Intersect ENT, Inc.'s (XENT) CEO Tom West on Q3 2020 Results - Earnings Call Transcript
04:12pm, Monday, 02'nd Nov 2020
Intersect ENT, Inc.'s (XENT) CEO Tom West on Q3 2020 Results - Earnings Call Transcript
